Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: A pooled-data analysis

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 291-295

  Zullo, Angelo ^a   Hassan, Cesare ^a   Andriani, Alessandro ^a   Cristofari, Francesca ^a   Bassanelli, Chiara ^a   Spinelli, Gian Paolo ^b   Tomao, Silverio ^b   Morini, Sergio ^a  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Gastric MALT lymphoma; Helicobacter pylori; Lymphoma remission; Oncologic therapy

Indexed keywords

CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; DRUG EFFICACY; ERADICATION THERAPY; HELICOBACTER PYLORI; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; STOMACH LYMPHOMA; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT RESPONSE;

HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, NON-HODGKIN; STATISTICS AS TOPIC; STOMACH NEOPLASMS;

EID: 77955827267     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9207-y     Document Type: Article

References (52)

1. Cavalli F, et al. MALT lymphomas. HematologyAm Soc Hematol Educ Program. 2001;241-58. doi:10.1182/asheducation-2001.1. 241.
2. Stolte M, et al. Helicobacter pylori and gastric MALT lymphoma. Gut. 2002;50(Suppl 3):19-24. doi:10.1136/gut.50.suppl-3.iii19.
3. Andriani A, et al. Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre study. Aliment Pharmacol Ther. 2006;23:721-6. doi:10.1111/j.1365-2036.2006.02826.x. (Pubitemid 43344590)
4. Malfertheiner P, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht III consensus report. Gut. 2007;56:772-81. doi:10.1136/gut.2006.101634. (Pubitemid 46854190)
5. Chey WD, Wong BCY. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1-18. doi:10.1111/j.1572-0241. 2007.01393.x.
6. Fujioka T, et al. Guidelines for the management of Helicobacter pylori infection in Japan: current status and future prospects. J Gastroenterol. 2007;42(Suppl 17):3-6. doi:10.1007/s00535-006- 1938-3.
7. CaselliM, et al. Cervia IIWorkingGroup Report 2006: guidelines on diagnosis and treatment ofHelicobacter pylori infection in Italy.Dig Liver Dis. 2007;39:782-9. doi:10.1016/j.dld.2007.05.016.
8. Zinzani PL. Thoughts on the eradication of Helicobacter pylori infection in localized gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma. 2006;47:2013-4. doi:10.1080/1042 8190600774873.
9. Andriani A, et al. Management and long-term follow up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicenter study. Dig Liver Dis. 2008 [Epub ahead of print].
10. Savio A, et al. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: True relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. Recent Results Cancer Res. 2000;156:116-24.
11. Papa A, et al. Helicobacter pylori eradication and remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma: a long-term follow-up study. J Clin Gastroenterol. 2000;31:169-71. doi:10.1097/00004836-200009000- 00018.
12. Caletti G, et al. The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma. Aliment Pharmacol Ther. 2002;16:1715-22. doi: 10.1046/j.1365-2036.2002.01334.x.
13. Levy M, et al. Conservative treatment of primary gastric lowgrade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol. 2002;97:292-7. doi:10.1111/j.1572-0241.2002. 05460.x.
14. Nakamura S, et al. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer. 2005;104:532-40. doi:10.1002/cncr.21152. (Pubitemid 41022810)
15. Akamatsu T, et al. Comparison of localized gastric mucosaassociated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection. Helicobacter. 2006;11:86-95. doi: 10.1111/j.1523-5378.2006.00382.x. (Pubitemid 43363307)
16. Steinbach G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: an uncontrolled trial. Ann Intern Med. 1999;131:88-95.
17. Sugimoto M, et al. Outcome of radiotherapy for gastric mucosaassociated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy. Intern Med. 2006;45:405-9. doi: 10.2169/internalmedicine.45.1473.
18. Raderer M, et al. Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease. Ann Oncol. 2001;12:937-9. doi:10.1023/A:1011122904602. (Pubitemid 32725765)
19. Terai S, et al. Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy. Tohoku J Exp Med. 2008;214:79-87. doi:10.1620/tjem. 214.79.
20. Begum S, et al. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases. J Med Invest. 2000;47:36-46.
21. Agresta F, et al. Gastric MALT lymphomas: the value of an endoscopic follow-up evaluation. Surg Endosc. 2000;14:1153-5. doi:10.1007/s004640000239. (Pubitemid 32060366)
22. El-Zahabi LM, et al. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication. Gastrointest Endosc. 2007;65:89-96. doi:10.1016/j.gie.2006.05.009. (Pubitemid 44932160)
23. de Jong D, et al. Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma. J Pathol. 2001;193:318-24. doi:10.1002/1096-9896(2000)9999:9999<:: AID-PATH811>3.0. CO;2-Z.
24. Kawahara Y, et al. HLA-DQA1*0103-DQB1*0601 haplotype and Helicobacter pylori-positive gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 2005;3:865-8. doi: 10.1016/S1542-3565(05)00185-0. (Pubitemid 41219288)
25. Matsushima Y, et al. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach Are there any useful markers for predicting outcome after Helicobacter pylori eradication? J Gastroenterol. 2002;37:428-33. doi: 10.1007/s005350200062. (Pubitemid 34846284)
26. Kim YS, et al. Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: Possible association with p16 hypermethylation. J Gastroenterol. 2002;37:17-22. doi:10.1007/s535-002- 8127-8.
27. Sheu BS, et al. Clinical application of 20 MHZ endosonography and anti-Helicobacter pylori immunoblots to predict regression of low-grade gastric Maltoma by H. pylori eradication. Helicobacter. 2003;8:36-45. doi:10.1046/j.1523-5378.2003.00122.x. (Pubitemid 36389541)
28. Ohashi S, et al.Gastrin and Helicobacter pylori in low-gradeMALT lymphoma patients. Scand J Gastroenterol. 2002;37:279-86. doi: 10.1080/ 003655202317284174. (Pubitemid 34194813)
29. Wündisch T, et al. Helicobacter pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma: results of a 196-patient series. Leuk Lymphoma. 2006;47:2110-4. doi:10.1080/ 10428190600783536. (Pubitemid 44650087)
30. Montalban C, et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): A 10-year updated follow-up of a prospective study. Ann Oncol. 2005;16:1539-44. doi:10.1093/ annonc/mdi277.
31. Dong G, et al. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma. Int J Hematol. 2008; 88:516-23. doi:10.1007/s12185-008-0187-z.
32. Noy A, et al. Gastric mucosa-associated lymphoid tissue lymphoma detected by clonotypic polymerase chain reaction despite continuous pathologic remission induced by involved-field radiotherapy. J Clin Oncol. 2005;23:3768-72. doi:10.1200/JCO. 2005.10.018.
33. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosaassociated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 1998;16:1916-21.
34. Jager G, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol. 2002;20:3872-7. doi:10.1200/JCO. 2002.05.117.
35. Martinelli G, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not elegible for anti-Helicobacter pylori therapy. J Clin Oncol. 2005;23: 1979-83. doi:10.1200/JCO.2005.08.128. (Pubitemid 46211377)
36. de Mascarel A, et al. Clinical, histological and molecular followup of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Arch. 2005;446: 219-24. doi:10.1007/s00428-005-1217-3. (Pubitemid 40558375)
37. Lee SK, et al. Low grade gastric mucosa associated lymphoid tissue lymphoma: Treatment strategies based on 10 year followup. World J Gastroenterol. 2004;10:223-6.
38. Wündisch T, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005; 23:8018-24. doi:10.1200/JCO.2005.02.3903. (Pubitemid 46657403)
39. Hong SS, et al. A prospective analysis of low-grade gastric MALT lymphoma after Helicobacter pylori eradication. Helicobacter. 2006;11:569-73. doi:10.1111/j.1523-5378.2006.00460.x. (Pubitemid 44674142)
40. Fischbach W, et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut. 2004; 53:34-7. doi:10.1136/gut.53.1.34. (Pubitemid 38083007)
41. Wenston AP, et al. Prospective long-termendoscopic and histologic follow-up of gastric lymphoproliferative disease of early stage I.E low-gared B-cellmucosa-associated lymphoid tissue type following Helicobacter pylori eradication treatment. Int J Oncol. 1999;15: 899-907.
42. Ishii E, et al. Immunoglobulin G1 antibody response to Helicobacter pylori heat shock protein 60 is closely associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma. Clin Diagn Lab Immunol. 2001;8:1056-9. doi:10.1128/CDLI.8.6. 1056-1059.2001.
43. Bertoni F, et al. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood. 2002;99:2541-4. doi:10.1182/blood.V99.7.2541. (Pubitemid 34525443)
44. Kim JS, et al. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease. Br J Cancer. 2007;96:1324-8.
45. Takenaka R, et al. Serum antibodies to Helicobacter pylori and its heat-shock protein 60 correlate with the response of gastric mucosa-associated lymphoid tissue lymphoma to eradication of H. pylori. Helicobacter. 2004;9:194-200. doi:10.1111/j.1083- 4389.2004.00225.x.
46. Kanda M, et al. Changes in patterns of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma. 2002;42: 639-47. doi:10.3109/10428190109099324.
47. Ono S, et al. Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosaassociated lymphoid tissue, including changes after treatment. Gastrointest Endosc. 2008;68:624-31. doi:10.1016/j.gie.2008.02. 066.
48. 53 and K-ras alteration and microsatellite instability. Int J Oncol. 2001;18:1207-12.
49. de mascarel A, et al. Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosaassociated lymphoid tissue. Virchows Arch. 2005;446:219-24.
50. Raderer M, et al. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut. 2006;55:616-8. doi:10.1136/gut.2005.083022.
51. Zucca E, Dreyling M. Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19(Suppl 2):70-1.
52. Fischbach W, et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut. 2007;56:1685-7. doi:10.1136/gut.2006.096420. (Pubitemid 350206294)